Clinical Trial Update: Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an anti-PD-1 antibody and pegaspargase with radiotherapy for early-stage Extranodal NK/T-cell Lymphoma, Nasal Type.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Anti-PD-1 antibody
• Pegaspargase (pegaspargase)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | Status: UNKNOWN